Ainhoa Lapitz

1.1k total citations
13 papers, 312 citations indexed

About

Ainhoa Lapitz is a scholar working on Surgery, Epidemiology and Molecular Biology. According to data from OpenAlex, Ainhoa Lapitz has authored 13 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Ainhoa Lapitz's work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Liver Diseases and Immunity (5 papers). Ainhoa Lapitz is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Liver Diseases and Immunity (5 papers). Ainhoa Lapitz collaborates with scholars based in Spain, Netherlands and Italy. Ainhoa Lapitz's co-authors include Jesús M. Bañales, Luís Bujanda, Ander Arbelaiz, María J. Perugorria, Paula Olaizola, Matías A. Ávila, Adelaida La Casta, Rocı́o I.R. Macı́as, Maria Luz Martínez‐Chantar and Cristina Alonso and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and Journal of Hepatology.

In The Last Decade

Ainhoa Lapitz

13 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ainhoa Lapitz Spain 8 150 121 114 99 68 13 312
Xiong Ding China 9 158 1.1× 54 0.4× 75 0.7× 93 0.9× 69 1.0× 21 334
Chengyun Dou China 10 110 0.7× 72 0.6× 36 0.3× 69 0.7× 64 0.9× 19 262
Lisheng Zhang China 7 141 0.9× 64 0.5× 75 0.7× 83 0.8× 72 1.1× 16 329
Liangtao Ye Germany 8 186 1.2× 173 1.4× 40 0.4× 65 0.7× 48 0.7× 18 342
K Umeshita Japan 12 87 0.6× 85 0.7× 108 0.9× 78 0.8× 117 1.7× 17 356
Shima Mimura Japan 10 325 2.2× 173 1.4× 72 0.6× 81 0.8× 74 1.1× 41 495
Jörg‐Martin Bangen Germany 5 205 1.4× 47 0.4× 39 0.3× 111 1.1× 89 1.3× 6 365
Beatrice Foglia Italy 10 142 0.9× 111 0.9× 46 0.4× 238 2.4× 147 2.2× 19 403
Fudong Lv China 9 159 1.1× 102 0.8× 44 0.4× 88 0.9× 84 1.2× 13 312
Qinghui Niu China 12 210 1.4× 160 1.3× 29 0.3× 92 0.9× 41 0.6× 27 365

Countries citing papers authored by Ainhoa Lapitz

Since Specialization
Citations

This map shows the geographic impact of Ainhoa Lapitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ainhoa Lapitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ainhoa Lapitz more than expected).

Fields of papers citing papers by Ainhoa Lapitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ainhoa Lapitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ainhoa Lapitz. The network helps show where Ainhoa Lapitz may publish in the future.

Co-authorship network of co-authors of Ainhoa Lapitz

This figure shows the co-authorship network connecting the top 25 collaborators of Ainhoa Lapitz. A scholar is included among the top collaborators of Ainhoa Lapitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ainhoa Lapitz. Ainhoa Lapitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Giorgio, Cristina Di, Silvia Marchianò, Michele Biagioli, et al.. (2025). Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice. Liver International. 45(2). e16235–e16235. 5 indexed citations
2.
Baldán‐Martín, Montserrat, Mikel Azkargorta, Ainhoa Lapitz, et al.. (2025). Proteomic Profiling of Extracellular Vesicles in Inflammatory Bowel Diseases. International Journal of Molecular Sciences. 26(2). 526–526. 2 indexed citations
3.
Fonseca, Paula Luize Camargos, Rodrigo Bentes Kato, Aline B.M. Vaz, et al.. (2024). Identification of taxonomic changes in the fecal bacteriome associated with colorectal polyps and cancer: potential biomarkers for early diagnosis. Frontiers in Microbiology. 14. 1292490–1292490. 8 indexed citations
4.
Arrese, Marco, Patricia Aspichueta, Cláudia P. Oliveira, et al.. (2024). Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD). Atherosclerosis. 400. 119053–119053. 16 indexed citations
5.
Lapitz, Ainhoa, Marit M. Grimsrud, Pedro M. Rodrigues, et al.. (2024). OS-076-YI Bile extracellular vesicles hold protein biomarkers for the early diagnosis of cholangiocarcinoma in individuals with primary sclerosing cholangitis. Journal of Hepatology. 80. S50–S50. 1 indexed citations
6.
Bañales, Jesús M., Ainhoa Lapitz, & Luca Fabris. (2024). Comparative performance of methylation DNA markers, brushing cytology, and FISH in diagnosing malignant biliary strictures. Hepatology. 81(2). 389–392. 1 indexed citations
7.
Macı́as, Rocı́o I.R., Luis Muñoz‐Bellvís, Enara Arretxe, et al.. (2020). A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. Cancers. 12(6). 1433–1433. 20 indexed citations
8.
Hernández, Alejandra, Juan Pablo Arab, Ainhoa Lapitz, et al.. (2020). Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy. Cells. 9(4). 817–817. 43 indexed citations
9.
Santos‐Laso, Álvaro, Laura Izquierdo‐Sánchez, Pedro M. Rodrigues, et al.. (2020). Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets. Liver International. 40(7). 1670–1685. 20 indexed citations
10.
Bañales, Jesús M., Mercedes Iñarrairaegui, Ander Arbelaiz, et al.. (2019). SAT-425-Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis. Journal of Hepatology. 70(1). e821–e822. 1 indexed citations
11.
Lapitz, Ainhoa, Ander Arbelaiz, Paula Olaizola, et al.. (2018). Extracellular Vesicles in Hepatobiliary Malignancies. Frontiers in Immunology. 9. 2270–2270. 29 indexed citations
12.
Bañales, Jesús M., Mercedes Iñarrairaegui, Ander Arbelaiz, et al.. (2018). Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis. Hepatology. 70(2). 547–562. 132 indexed citations
13.
Olaizola, Paula, Pui Yuen Lee, Ander Arbelaiz, et al.. (2017). MicroRNAs and extracellular vesicles in cholangiopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(4). 1293–1307. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026